Lokeshwar BL - Search Results

1

Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence.

Cohen BL, Gomez P, Omori Y, Duncan RC, Civantos F, Soloway MS, Lokeshwar VB, Lokeshwar BL. Cohen BL, et al. Among authors: lokeshwar bl, lokeshwar vb. Int J Cancer. 2006 Sep 1;119(5):1082-7. doi: 10.1002/ijc.21749. Int J Cancer. 2006. PMID: 16557596

2

Ursolic Acid Analogs as Potential Therapeutics for Cancer.

Panda SS, Thangaraju M, Lokeshwar BL. Panda SS, et al. Among authors: lokeshwar bl. Molecules. 2022 Dec 16;27(24):8981. doi: 10.3390/molecules27248981. Molecules. 2022. PMID: 36558113 Free PMC article. Review.

3

Development of a Transparent Transgenic Zebrafish Cellular Phenotype Tg(6xNF-kB:EGFP); Casper(roy^-/-, nacre^-/-) to Study NF-kB Activity.

Rajpurohit SK, Ouellette L, Sura S, Appiah C, O'Keefe A, McCarthy K, Kandepu U, Ye Mon M, Kimmerling K, Arora V, Lokeshwar BL. Rajpurohit SK, et al. Among authors: lokeshwar bl. Biomedicines. 2023 Jul 13;11(7):1985. doi: 10.3390/biomedicines11071985. Biomedicines. 2023. PMID: 37509624 Free PMC article.

4

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.

Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM. Lokeshwar BL, et al. Int J Cancer. 2002 Mar 10;98(2):297-309. doi: 10.1002/ijc.10168. Int J Cancer. 2002. PMID: 11857423

5

Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs.

Dandekar DS, Lokeshwar BL. Dandekar DS, et al. Among authors: lokeshwar bl. Clin Cancer Res. 2004 Dec 1;10(23):8037-47. doi: 10.1158/1078-0432.CCR-04-1208. Clin Cancer Res. 2004. PMID: 15585639

6

Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.

Dandekar DS, Lopez M, Carey RI, Lokeshwar BL. Dandekar DS, et al. Among authors: lokeshwar bl. Int J Cancer. 2005 Jun 20;115(3):484-92. doi: 10.1002/ijc.20878. Int J Cancer. 2005. PMID: 15688368

7

HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.

Lokeshwar VB, Cerwinka WH, Lokeshwar BL. Lokeshwar VB, et al. Among authors: lokeshwar bl. Cancer Res. 2005 Mar 15;65(6):2243-50. doi: 10.1158/0008-5472.CAN-04-2805. Cancer Res. 2005. PMID: 15781637

8

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.

Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL. Lokeshwar VB, et al. Among authors: lokeshwar bl. Cancer Res. 2005 Sep 1;65(17):7782-9. doi: 10.1158/0008-5472.CAN-05-1022. Cancer Res. 2005. PMID: 16140946

9

HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.

Lokeshwar VB, Estrella V, Lopez L, Kramer M, Gomez P, Soloway MS, Lokeshwar BL. Lokeshwar VB, et al. Among authors: lokeshwar bl. Cancer Res. 2006 Dec 1;66(23):11219-27. doi: 10.1158/0008-5472.CAN-06-1121. Cancer Res. 2006. PMID: 17145867

10

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.

Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL. Araki S, et al. Among authors: lokeshwar bl, lokeshwar vb. Cancer Res. 2007 Jul 15;67(14):6854-62. doi: 10.1158/0008-5472.CAN-07-1162. Cancer Res. 2007. PMID: 17638896 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters